Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Neuroendocrine Tumors - Pipeline Insight,...
-
Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapies for Cancer Treatment: Global Market" report has been added to ResearchAndMarkets.com's offering.The report provides an...
-
Dublin, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The "Gastroenteropancreatic Neuroendocrine Tumors Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region -...
-
Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" has been added to ...
-
Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Gastric Neuroendocrine Tumors Market" report has been added to ResearchAndMarkets.com's offering. The gastric neuroendocrine tumor (gNET) market,...
-
Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" report has been added to ...
-
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...
-
New York, USA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Neuroendocrine Tumors Market to Showcase Rapid Growth During the Study Period (2020–2034), at a CAGR of 5.1%| DelveInsight The launch of upcoming...
-
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of...